SomnoMed Inkomsten in het verleden

Verleden criteriumcontroles 0/6

De winst van SomnoMed is gedaald met een gemiddeld jaarlijks percentage van -60.8%, terwijl de winst van de Medical Equipment -industrie jaarlijks groeide met 8.3%. De inkomsten zijn groeide met een gemiddeld percentage van 10.5% per jaar.

Belangrijke informatie

-60.8%

Groei van de winst

-56.4%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie5.8%
Inkomstengroei10.5%
Rendement op eigen vermogen-27.2%
Nettomarge-13.4%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Benign Growth For SomnoMed Limited (ASX:SOM) Underpins Stock's 27% Plummet

Oct 16
Benign Growth For SomnoMed Limited (ASX:SOM) Underpins Stock's 27% Plummet

SomnoMed Limited's (ASX:SOM) Share Price Boosted 30% But Its Business Prospects Need A Lift Too

Jul 15
SomnoMed Limited's (ASX:SOM) Share Price Boosted 30% But Its Business Prospects Need A Lift Too

SomnoMed Limited (ASX:SOM) Shares Fly 30% But Investors Aren't Buying For Growth

May 31
SomnoMed Limited (ASX:SOM) Shares Fly 30% But Investors Aren't Buying For Growth

SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Apr 15
SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Mar 04
SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)

Dec 21
Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)

SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks

Sep 02
SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks

Is SomnoMed (ASX:SOM) Using Too Much Debt?

Jun 19
Is SomnoMed (ASX:SOM) Using Too Much Debt?

It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year

Nov 18
It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year

SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Sep 27
SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?

Is SomnoMed (ASX:SOM) Using Debt Sensibly?

May 10
Is SomnoMed (ASX:SOM) Using Debt Sensibly?

Is SomnoMed (ASX:SOM) Using Debt Sensibly?

Oct 26
Is SomnoMed (ASX:SOM) Using Debt Sensibly?

Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?

May 12
Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?

Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?

Mar 02
Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?

Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?

Feb 01
Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?

Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?

Dec 28
Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?

Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?

Dec 01
Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?

Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)

Jul 28
Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)

SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings

Jul 14
SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings

Opbrengsten en kosten

Hoe SomnoMed geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

ASX:SOM Opbrengsten, kosten en inkomsten (AUD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 2492-12580
31 Mar 2490-11560
31 Dec 2389-11560
30 Sep 2386-9530
30 Jun 2384-8500
31 Mar 2381-7490
31 Dec 2279-5480
30 Sep 2276-5460
30 Jun 2273-4440
31 Mar 2269-5430
31 Dec 2166-5410
30 Sep 2164-3380
30 Jun 2163-1350
31 Mar 2159-1320
31 Dec 2055-1300
30 Sep 2056-1300
30 Jun 20570310
31 Mar 20600320
31 Dec 19631330
30 Sep 19610320
30 Jun 19590320
31 Mar 19582320
31 Dec 18563310
30 Sep 18543300
30 Jun 18522290
31 Mar 1851-1300
31 Dec 1750-4320
30 Sep 1750-4320
30 Jun 1749-3310
31 Mar 1748-2290
31 Dec 1647-1260
30 Sep 16450250
30 Jun 16440240
31 Mar 16420230
31 Dec 15391210
30 Sep 15371200
30 Jun 15341190
31 Mar 15341180
31 Dec 14351180
30 Sep 14321170
30 Jun 14300160
31 Mar 14260150
31 Dec 13220140

Kwaliteitswinsten: SOM is momenteel verliesgevend.

Groeiende winstmarge: SOM is momenteel verliesgevend.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: SOM is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 60.8% per jaar.

Versnelling van de groei: Het is niet mogelijk om de winstgroei van SOM over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.

Winst versus industrie: SOM is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Medical Equipment industrie ( 18.7% ).


Rendement op eigen vermogen

Hoge ROE: SOM heeft een negatief Return on Equity ( -27.19% ), omdat het momenteel verliesgevend is.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden